EOGT gene
The EOGT gene provides instructions for a protein that modifies other proteins to regulate cellular signaling and development.
Normal Function
The EOGT gene provides instructions for making a protein that modifies other proteins by transferring a molecule called N-acetylglucosamine to them. This process, known as O-GlcNAc modification, can affect protein stability and regulate cellular processes such as signaling and transcription.
Studies suggest that Notch proteins may be modified by EOGT. Notch proteins stimulate signaling pathways that are vital during the development of various tissues, including bones, heart, liver, muscles, and blood cells.
Health Conditions Related to Genetic Changes
Adams-Oliver syndrome
At least three mutations in the EOGT gene have been identified in individuals with Adams-Oliver syndrome, a condition characterized by areas of missing skin (aplasia cutis congenita), usually on the scalp, and malformations of the hands and feet.
The most common EOGT mutation, found in the Arab population, leads to an abnormally short protein. Other mutations change single amino acids in the EOGT protein. Research indicates that these mutations reduce or eliminate the protein's ability to transfer N-acetylglucosamine, though the exact mechanism by which this impairment leads to the features of Adams-Oliver syndrome remains unknown.
Other Names for This Gene
- AER61
- AER61 glycosyltransferase
- AOS4
- C3orf64
- EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase
- EGF domain-specific O-linked N-acetylglucosamine transferase
- EGF-O-GlcNAc transferase
- EOGT1
- EOGT_HUMAN
- extracellular O-linked N-acetylglucosamine transferase
- FLJ33770